199 related articles for article (PubMed ID: 18541728)
21. Mitochondrial changes during D-drug-containing once-daily therapy in HIV-positive treatment-naive patients.
Maggiolo F; Roat E; Pinti M; Nasi M; Gibellini L; De Biasi S; Airoldi M; Ravasio V; Mussini C; Suter F; Cossarizza A
Antivir Ther; 2010; 15(1):51-9. PubMed ID: 20167991
[TBL] [Abstract][Full Text] [Related]
22. Progressive mitochondrial compromise in brains and livers of primates exposed in utero to nucleoside reverse transcriptase inhibitors (NRTIs).
Divi RL; Einem TL; Fletcher SL; Shockley ME; Kuo MM; St Claire MC; Cook A; Nagashima K; Harbaugh SW; Harbaugh JW; Poirier MC
Toxicol Sci; 2010 Nov; 118(1):191-201. PubMed ID: 20702595
[TBL] [Abstract][Full Text] [Related]
23. Upregulatory mechanisms compensate for mitochondrial DNA depletion in asymptomatic individuals receiving stavudine plus didanosine.
Miró O; López S; Rodríguez de la Concepción M; Martínez E; Pedrol E; Garrabou G; Giralt M; Cardellach F; Gatell JM; Vilarroya F; Casademont J
J Acquir Immune Defic Syndr; 2004 Dec; 37(5):1550-5. PubMed ID: 15577406
[TBL] [Abstract][Full Text] [Related]
24. Changes in mitochondrial RNA production in cells treated with nucleoside analogues.
Galluzzi L; Pinti M; Troiano L; Prada N; Nasi M; Ferraresi R; Salomoni P; Mussini C; Cossarizza A
Antivir Ther; 2005; 10(1):191-5. PubMed ID: 15751778
[TBL] [Abstract][Full Text] [Related]
25. Cellular and mitochondrial toxicity of zidovudine (AZT), didanosine (ddI) and zalcitabine (ddC) on cultured human muscle cells.
Benbrik E; Chariot P; Bonavaud S; Ammi-Saïd M; Frisdal E; Rey C; Gherardi R; Barlovatz-Meimon G
J Neurol Sci; 1997 Jul; 149(1):19-25. PubMed ID: 9168161
[TBL] [Abstract][Full Text] [Related]
26. Greater and more rapid depletion of mitochondrial DNA in blood of patients treated with dual (zidovudine+didanosine or zidovudine+zalcitabine) vs. single (zidovudine) nucleoside reverse transcriptase inhibitors.
Reiss P; Casula M; de Ronde A; Weverling GJ; Goudsmit J; Lange JM
HIV Med; 2004 Jan; 5(1):11-4. PubMed ID: 14731163
[TBL] [Abstract][Full Text] [Related]
27. Effects of a nucleoside reverse transcriptase inhibitor, stavudine, on glucose disposal and mitochondrial function in muscle of healthy adults.
Fleischman A; Johnsen S; Systrom DM; Hrovat M; Farrar CT; Frontera W; Fitch K; Thomas BJ; Torriani M; Côté HC; Grinspoon SK
Am J Physiol Endocrinol Metab; 2007 Jun; 292(6):E1666-73. PubMed ID: 17284576
[TBL] [Abstract][Full Text] [Related]
28. Increased long-term mitochondrial toxicity in combinations of nucleoside analogue reverse-transcriptase inhibitors.
Walker UA; Setzer B; Venhoff N
AIDS; 2002 Nov; 16(16):2165-73. PubMed ID: 12409738
[TBL] [Abstract][Full Text] [Related]
29. Mitochondrial DNA content of peripheral blood mononuclear cells in ART untreated & stavudine/zidovudine treated HIV-1-infected patients.
Subashini D; Dinesha TR; Srirama RB; Boobalan J; Poongulali S; Chitra DA; Mothi SN; Solomon SS; Saravanan S; Solomon S; Balakrishnan P
Indian J Med Res; 2018 Aug; 148(2):207-214. PubMed ID: 30381544
[TBL] [Abstract][Full Text] [Related]
30. Accumulation of mitochondrial DNA mutations in human immunodeficiency virus-infected patients treated with nucleoside-analogue reverse-transcriptase inhibitors.
Martin AM; Hammond E; Nolan D; Pace C; Den Boer M; Taylor L; Moore H; Martinez OP; Christiansen FT; Mallal S
Am J Hum Genet; 2003 Mar; 72(3):549-60. PubMed ID: 12587093
[TBL] [Abstract][Full Text] [Related]
31. Prevalence of lipoatrophy and mitochondrial DNA content of blood and subcutaneous fat in HIV-1-infected patients randomly allocated to zidovudine- or stavudine-based therapy.
van der Valk M; Casula M; Weverlingz GJ; van Kuijk K; van Eck-Smit B; Hulsebosch HJ; Nieuwkerk P; van Eeden A; Brinkman K; Lange J; de Ronde A; Reiss P
Antivir Ther; 2004 Jun; 9(3):385-93. PubMed ID: 15259901
[TBL] [Abstract][Full Text] [Related]
32. Three-drug combinations of emivirine and nucleoside reverse transcriptase inhibitors in vitro: long-term culture of HIV-1-infected cells and breakthrough viruses.
Nitanda T; Wang X; Somekawa K; Yuasa S; Baba M
Antivir Chem Chemother; 2001 May; 12(3):161-7. PubMed ID: 12959324
[TBL] [Abstract][Full Text] [Related]
33. Mitochondrial proliferation, DNA depletion and adipocyte differentiation in subcutaneous adipose tissue of HIV-positive HAART recipients.
Pace CS; Martin AM; Hammond EL; Mamotte CD; Nolan DA; Mallal SA
Antivir Ther; 2003 Aug; 8(4):323-31. PubMed ID: 14518702
[TBL] [Abstract][Full Text] [Related]
34. Depleted skeletal muscle mitochondrial DNA, hyperlactatemia, and decreased oxidative capacity in HIV-infected patients on highly active antiretroviral therapy.
Haugaard SB; Andersen O; Pedersen SB; Dela F; Richelsen B; Nielsen JO; Madsbad S; Iversen J
J Med Virol; 2005 Sep; 77(1):29-38. PubMed ID: 16032748
[TBL] [Abstract][Full Text] [Related]
35. Mitochondrial defects arise from nucleoside/nucleotide reverse transcriptase inhibitors in neurons: Potential contribution to HIV-associated neurocognitive disorders.
Hung KM; Chen PC; Hsieh HC; Calkins MJ
Biochim Biophys Acta Mol Basis Dis; 2017 Feb; 1863(2):406-413. PubMed ID: 27840304
[TBL] [Abstract][Full Text] [Related]
36. Mitochondrial DNA depletion and respiratory chain activity in primary human subcutaneous adipocytes treated with nucleoside analogue reverse transcriptase inhibitors.
Stankov MV; Lücke T; Das AM; Schmidt RE; Behrens GM
Antimicrob Agents Chemother; 2010 Jan; 54(1):280-7. PubMed ID: 19805555
[TBL] [Abstract][Full Text] [Related]
37. [Immunological effectiveness of the nucleoside/nucleotide analog combinations, tenofovir + lamivudine, didanosine + lamivudine and tenofovir + didanosine, in patients with HIV infection and sustained viral suppression].
Cervero M; Torres R; Jusdado JJ; Rodríguez-Rosado R; Del Alamo M; García-Benaya E
Enferm Infecc Microbiol Clin; 2006; 24(7):426-30. PubMed ID: 16956530
[TBL] [Abstract][Full Text] [Related]
38. Centrosome amplification induced by the antiretroviral nucleoside reverse transcriptase inhibitors lamivudine, stavudine, and didanosine.
Yu M; Ward Y; Poirier MC; Olivero OA
Environ Mol Mutagen; 2009 Oct; 50(8):718-24. PubMed ID: 19562754
[TBL] [Abstract][Full Text] [Related]
39. The nucleoside reverse transcriptase inhibitors didanosine, lamivudine, stavudine and zidovudine show little effect on the virulence of Candida albicans in vitro.
Ahmadou Ahidjo B; Veale R; Dusé AG; Becker P; Marais E
Int J Antimicrob Agents; 2008 Aug; 32(2):186-91. PubMed ID: 18571385
[TBL] [Abstract][Full Text] [Related]
40. Cardiac mitochondrial compromise in 1-yr-old Erythrocebus patas monkeys perinatally-exposed to nucleoside reverse transcriptase inhibitors.
Divi RL; Leonard SL; Kuo MM; Walker BL; Orozco CC; St Claire MC; Nagashima K; Harbaugh SW; Harbaugh JW; Thamire C; Sable CA; Poirier MC
Cardiovasc Toxicol; 2005; 5(3):333-46. PubMed ID: 16244378
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
